Canaccord Genuity Assumes Lipocine Inc (LPCN) at Buy
Tweet
Share
E-mailGet Alerts LPCN Hot Sheet
Price: $2.06 +0.98%
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Join SI Premium – FREE
Canaccord Genuity assumed coverage on Lipocine Inc (NASDAQ: LPCN) with a Buy rating and a price target of $15.00.
For an analyst ratings summary and ratings history on Lipocine Inc click here. For more ratings news on Lipocine Inc click here.
Shares of Lipocine Inc closed at $3.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Starts Aktis Oncology (AKTS) at Outperform
- Alliance Global Partners Starts DarioHealth Corp. (DRIO) at Buy
- BMO Capital Starts Ascendis Pharma (ASND) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
